GlycoPure Overview

  • Founded
  • 2010
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

GlycoPure General Information


Developer of a medical technology designed to offer a process for producing glucosamine. The company's technology is focused on a genetically-modified bacterium which produces pure forms of glucosamine and N-acetylglucosamine from chitin-containing materials, enabling healthcare professionals to develop useful protein for their patients to help them in faster recovery.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Drug Discovery
Primary Office
  • 306 Mill Street
  • Cambridge, MD 21613
  • United States
+1 (410) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

GlycoPure Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Out of Business 11-Oct-2019 00.000 Completed Out of Business
7. Debt - General 24-Oct-2016 00000 00.000 Completed Startup
6. Grant 01-Jan-2014 00000 00000 Completed Startup
5. Early Stage VC 01-Aug-2013 00000 00000 Completed Startup
4. Early Stage VC 01-Sep-2012 0000 0000 Completed Startup
3. Accelerator/Incubator Completed Startup
2. Grant 10-Aug-2011 $165K Completed Startup
1. Equity Crowdfunding 26-Oct-2010 Completed Startup
To view GlycoPure’s complete valuation and funding history, request access »